Related Experiment Video
Updated: Apr 22, 2026

Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Effects of a Modified Exposure Claim for an e-Cigarette on Claim Comprehension, Behavioral Intentions, and Risk
Pierpaolo Magnani1, Medy Ehtesham1, Alexandre Soulan1
1Philip Morris International, Neuchâtel, Switzerland.
A modified exposure claim (MEC) about e-cigarettes (IQOS VEEV) was well-understood by adult tobacco users and nonusers. Claim exposure increased e-cigarette use intention among smokers and reduced perceived risk compared to cigarettes.
Area of Science:
- Public Health
- Tobacco Control
- Risk Communication
Background:
- Effective communication on relative risks of cigarettes and e-cigarettes is crucial for harm reduction.
- Understanding consumer perceptions of modified exposure claims (MECs) is vital for public health strategies.
Purpose of the Study:
- To examine comprehension of a proposed MEC for an e-cigarette (IQOS VEEV).
- To assess the impact of MEC exposure on e-cigarette use intentions and risk perceptions among diverse adult populations (users and nonusers of tobacco and nicotine products).
Main Methods:
- A randomized online experimental study involved 3852 adult participants across various categories: smokers intending to quit (S-IQ), smokers not intending to quit (S-NIQ), e-cigarette users (ECU), former smokers (FS), and never-users (aged 18-24 and 25+).
- Participants were exposed to a marketing brochure with or without an embedded MEC.
- Outcomes measured included claim comprehension, intention to use the study product (SP) regularly, and perceived health risks.
Main Results:
- Most participants understood the MEC, recognizing that the SP produces fewer harmful chemicals than cigarettes and switching reduces exposure.
- E-cigarette use intention was high among ECUs and increased significantly among S-IQ after MEC exposure.
- All groups perceived the SP as lower risk than cigarettes, and MEC exposure significantly reduced perceived SP risk relative to cigarettes across all participant groups.
Conclusions:
- The tested MEC effectively communicates reduced exposure benefits of the IQOS VEEV e-cigarette.
- The MEC has potential public health benefits by encouraging smokers to switch while maintaining low appeal to nonusers.
- This study highlights the importance of clear and accurate risk communication in tobacco harm reduction strategies.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Statistical Methods for Analyzing Epidemiological Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence
What is an Experiment?